Antibodies specific for plasmacytoid dendritic cells
AssigneeSchering Corporation
InventorsCarine Paturel, Giorgio Trinchieri, Jean-Jacques Pin
Life of this patent
Estimating the term…
Abstract
The invention provides immunological reagents (antibodies) capable of binding to plasmacytoid dendritic cells (pDC), to cell lines which express such antibodies and to a process for identifying and purifying plasmacytoid dendritic cells from tissues containing pDC using such antibodies.
Claims7
A binding compound having the binding characteristics of the monoclonal antibody produced by the hybridoma cell line deposited under ATCC Accession No. PTA-4957.
An antigen binding fragment of a monoclonal antibody produced by the hybridoma cell line deposited under ATCC Accession No. PTA-4957.
The monoclonal antibody produced by the hybridoma cell line deposited under ATCC Accession No. PTA-4957.
The hybridoma cell line deposited under ATCC Accession No. PTA-4957.
Dependencies are inferred from the claim text.